BE
BEVVF.US Bee Vectoring Technologies International Inc
- Market cap
- USD 20.3K
- P/E
- -
- P/B
- 0.05x
- ROE
- -699.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2024.
Is BEVVF.US undervalued?
Graham numberThe Graham number of Bee Vectoring Technologies International Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bee Vectoring Technologies International Inc fundamental analysis
No fundamental analysis for Bee Vectoring Technologies International Inc yet.
Bee Vectoring Technologies International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bee Vectoring Technologies International Inc
Bee Vectoring Technologies International Inc. focuses on the control of pests and enhancement of crops and ornamentals through biological controls in various application processes in the United States. Its solutions include Hive & Bees, an inoculum dispenser system; Vectorpak, a removable tray that contains Vectorite, a specially formulated patented powder made from various natural materials; active ingredients, such as BVT-CR7, an organic strain of a natural occurring fungu…
Full company profileBee Vectoring Technologies International Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bee Vectoring Technologies International Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 58.2K | 289K | 399K | 497K | 602K | 163K |
| Gross Profit | -17.6K | 0.00 | -82.7K | -92.9K | -96.9K | 13.3K | 112K | 167K | 246K | 318K | -4.05K |
| Operating Income | -70.5K | -2.99M | -2.61M | -2.99M | -2.93M | -2.95M | -6.57M | -3.81M | -4.19M | -3.47M | -3.25M |
| EBITDA | -476K | -1.17M | -2.30M | -2.52M | -2.57M | -2.82M | -6.54M | -3.93M | -3.93M | -4.24M | -3.07M |
| Net Income | -70.5K | -2.99M | -2.61M | -3.10M | -2.99M | -2.90M | -6.72M | -4.12M | -4.93M | -4.67M | -3.75M |
| EPS | 0.00 | -0.20 | -0.06 | -0.06 | -0.04 | -0.04 | -0.08 | -0.04 | -0.04 | -0.03 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 296K | 2.56M | 2.59M | 2.12M | 4.15M | 2.34M | 2.47M | 5.25M | 5.92M | 3.62M | 2.77M |
| Total Liabilities | 11.0K | 118K | 243K | 299K | 281K | 735K | 970K | 722K | 2.16M | 2.27M | 2.23M |
| Shareholders' Equity | 285K | 2.44M | 2.35M | 1.82M | 3.87M | 1.60M | 1.50M | 4.53M | 3.76M | 1.35M | 536K |
| Cash & Short-term Investments | 252K | 1.59M | 1.48M | 824K | 2.70M | 313K | 303K | 2.71M | 2.73M | 670K | 26.4K |
| Total Debt | 690K | 15.1K | - | - | - | 50.0K | 80.6K | 236K | 973K | 658K | 623K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -65.9K | -851K | -2.06M | -2.70M | -2.39M | -2.04M | -3.68M | -2.85M | -2.90M | -1.15M | -253K |
| Capital Expenditure | 206K | 412K | 356K | 215K | 379K | 645K | 380K | 352K | 225K | 227K | 5.23 |
| Free Cash Flow | -272K | -1.26M | -2.42M | -2.91M | -2.76M | -2.69M | -4.06M | -3.20M | -3.12M | -1.38M | -253K |
| Ratios | |||||||||||
| ROE | -24.7% | -122.6% | -111.3% | -170.5% | -77.3% | -181.1% | -447.6% | -91.0% | -131.1% | -345.7% | -699.6% |
| ROA | -23.8% | -116.9% | -100.9% | -146.5% | -72.1% | -124.1% | -271.8% | -78.5% | -83.3% | -129.2% | -135.7% |
| Net Profit Margin | - | - | - | - | - | -4,981.1% | -2,324.7% | -1,033.0% | -992.9% | -777.0% | -2,308.1% |
| Debt to Equity | 2.42x | 0.01x | - | - | - | 0.03x | 0.05x | 0.05x | 0.26x | 0.49x | 1.16x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bee Vectoring Technologies International Inc dividends
Bee Vectoring Technologies International Inc has not paid dividends in the last 9 fiscal years.
Who owns Bee Vectoring Technologies International Inc
- Insiders 0.00%
- Institutions 1.53%
- Public & others 98.47%
- Shares outstanding 203M
- Free float 189M
Bee Vectoring Technologies International Inc company profile
- Company name
- Bee Vectoring Technologies International Inc
- Ticker
- BEVVF.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Fiscal year end
- September
- Address
- 4160 Sladeview Crescent, Mississauga, ON, Canada, L5L 0A1
- Phone
- 647-660-5119
- Website
- beevt.com
About Bee Vectoring Technologies International Inc
Bee Vectoring Technologies International Inc. focuses on the control of pests and enhancement of crops and ornamentals through biological controls in various application processes in the United States. Its solutions include Hive & Bees, an inoculum dispenser system; Vectorpak, a removable tray that contains Vectorite, a specially formulated patented powder made from various natural materials; active ingredients, such as BVT-CR7, an organic strain of a natural occurring fungus; and pollen distribution systems. The company also provides pest and disease management solutions for various crops, such as strawberries, sunflowers, apples, tomatoes, canola crops, blueberries, caneberries, and other crops. The company is based in Mississauga, Canada.
Bee Vectoring Technologies International Inc management
2- Mr. Ashish MalikCEO, President & Director
- Mr. Kyle Michael Appleby CA, CPACorporate Secretary · born 1975